Longevity investment bulletin: Assured Allies, Fountain Life, Form Bio and more

Longevity investment bulletin: Assured Allies, Fountain Life, Form Bio and more

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

The latest longevity updates from our investment news desk.  

Assured Allies raises $42.5M

Longevity insurtech company Assured Allies announced a $42.5 million Series B funding round, bringing the total capital raised to $65 million. The company combines machine learning and predictive analytics with the latest aging science to offer successful aging programs designed to reduce the risk of disability, and next-generation retirement products that make long-term care insurance accessible and financially sustainable.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

LTUI: 2064

BioPhysical Therapeutics

Longevity level(s):

  • Level 6: Aging disease prevention therapeutics
    Therapeutic interventions that control aging drivers to prevent aging diseases from occurring, like the current wave of GLP-1 agonists that prevent type 2 diabetes through metabolic interventions that also are proving effective in mitigating cardiovascular and neurological diseases.
  • Level 7: Targeted aging disease reversal
    Therapeutic interventions that stop or reverse age-related damage in specific organs (organ specific / tissue specific / localized reversal) or for age-related diseases including technologies like partial cellular reprogramming.

Overview

BioPhysical Therapeutics is a computational biology-driven drug discovery platform company focused on designing novel therapeutics for cancer, age-related diseases including neurodegenerative conditions, and aging itself. The company employs biophysical modeling and computational simulations to identify and develop experimentally-validated drug candidates across preclinical and clinical stages. By targeting fundamental mechanisms of aging and metabolic regulation, BioPhysical Therapeutics aims to create interventions that extend healthspan and address the root causes of age-associated pathologies.

Access all data points on DLT:

  • Financial Data
  • Patents
  • Technology
  • Management
  • Advisory Board
  • News
  • Classifications
  • Similar Companies
Expand

LT Staff

Longevity.Technology's in-house writing staff.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Old dogs, new funding: Dog Aging Project fetches $29m from NIH

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE